Emaai Pharma Ltd.

Emaai Pharma Ltd. - chemicals in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U24239MH1992PLC066831 Incorporated 19 May 1992 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company chemicals
Data last updated
Revenue · FY 2017
-
Latest filing
EBITDA · FY 2017
*****
▲ 0.00% YoY
Net profit · FY 2017
*****
In full report
Authorised capital
₹4.5 Cr
Registered with MCA
Paid-up capital
₹4.11 Cr
Issued & subscribed
Open charges
None
Secured borrowings
Company age
34 yrs
Est. 1992
Last financials
Mar 2025
Balance sheet date

About Emaai Pharma Ltd.

Data last updated: 11 March 2026

Emaai Pharma Ltd. is a public limited company based in Mumbai, Maharashtra, India. It specialises in manufacturing, a part of the broader chemicals sector. Incorporated on 19 May 1992, the company has been in operation for over 34 years.

Registered with ROC Mumbai under CIN U24239MH1992PLC066831.

Capital: an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹4.11 Cr. It is led by directors including Madan Indermal Jain and Kiran Madhukar Sawant.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Shop No 4 Nekjat Maratha Sadan T. B. Kadam Marg Byculla, Mumbai, Maharashtra, India – 400027.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Emaai Pharma Ltd.
CIN U24239MH1992PLC066831
Registration Number 066831
Incorporation Date 19 May 1992
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Madan Indermal Jain Director Kiran Madhukar Sawant Director Sharad Lalji Singh Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Shop No 4 Nekjat Maratha Sadan T. B. Kadam Marg Byculla, Mumbai, Maharashtra, India – 400027
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Company report
Emaai Pharma Ltd. - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Emaai Pharma Ltd. report

Financials, compliance, directors, charges, ownership and filings for Emaai Pharma Ltd. in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Emaai Pharma Ltd.

Emaai Pharma Ltd. has one previous CIN (Corporate Identification Number): L24239MH1992PLC066831. The current CIN is U24239MH1992PLC066831, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24239MH1992PLC066831 Current
L24239MH1992PLC066831 Previous

Auditor Details of Emaai Pharma Ltd.

Emaai Pharma Ltd. is audited by PULKITBHARATKUMARBAFNA for the financial year 2017. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
PULKITBHARATKUMARBAFNA blur-value blur-value blur-value

Board of Directors of Emaai Pharma Ltd.

Emaai Pharma Ltd. is currently managed by 3 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Madan Indermal Jain Director 19 May 1992 34 Years 1 Months Current
Kiran Madhukar Sawant Director 18 Oct 2017 8 Years 8 Months Current
Sharad Lalji Singh Director 01 Nov 2017 8 Years 8 Months Current
View all directors

Financials of Emaai Pharma Ltd. FY 2025 filings available

Emaai Pharma Ltd. reported revenue of ₹- (up ) for FY 2017. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
-
EBITDA
*****
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Emaai Pharma Ltd.

As of FY 2017, Emaai Pharma Ltd.'s shareholding pattern shows 41.00% by promoters, 59.00% by public shareholders. Public shareholders hold the majority stake, reflecting broad public ownership.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings Emaai Pharma Ltd.

Emaai Pharma Ltd. does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Emaai Pharma Ltd.

View historical data on people associated with Emaai Pharma Ltd., including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Emaai Pharma Ltd.

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Emaai Pharma Ltd.

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Emaai Pharma Ltd.

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Emaai Pharma Ltd.

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Emaai Pharma Ltd.

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Emaai Pharma Ltd.

MSME Payment Delays by Emaai Pharma Ltd.

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Emaai Pharma Ltd.

Subsidiaries & Group Companies of Emaai Pharma Ltd.

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Emaai Pharma Ltd. with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Emaai Pharma Ltd.

MCA Filings & Documents of Emaai Pharma Ltd.

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Emaai Pharma Ltd.

Activity
30 Sep 2025
Emaai Pharma Ltd. last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Emaai Pharma Ltd. has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Directors
01 Nov 2017
Sharad Lalji Singh was appointed as a Director on 01 Nov 2017 & has been associated with this company since 8 years 8 months.
Directors
18 Oct 2017
Kiran Madhukar Sawant was appointed as a Director on 18 Oct 2017 & has been associated with this company since 8 years 8 months.
Directors
19 May 1992
Madan Indermal Jain was appointed as a Director on 19 May 1992 & has been associated with this company since 34 years 1 month.
Activity
19 May 1992
Emaai Pharma Ltd. was registered on 19 May 1992 with Roc Mumbai I & aged 34 years 1 month as per MCA records.

Frequently Asked Questions about Emaai Pharma Ltd.

Emaai Pharma Ltd. is an active public limited company in the chemicals sector based in Mumbai, Maharashtra, India. It was incorporated on 19 May 1992 (34+ years old) and is registered under CIN U24239MH1992PLC066831.

The current directors of Emaai Pharma Ltd. are:

The primary industry of Emaai Pharma Ltd. is chemicals. The company specifically operates in manufacturing. The company is currently active in this sector.

Emaai Pharma Ltd. can be reached at the registered office: Shop No 4 Nekjat Maratha Sadan T. B. Kadam Marg Byculla, Mumbai, Maharashtra, India – 400027.

The authorised capital is ₹4.5 Cr, and the paid-up capital is ₹4.11 Cr.

The company has its registered office at Shop No 4 Nekjat Maratha Sadan T. B. Kadam Marg Byculla, Mumbai, Maharashtra, India – 400027.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available